RepliCel Life Sciences (TSE:RP) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
RepliCel Life Sciences is urging shareholders to access its management information circular online due to possible postal delays caused by a Canada Post labor disruption. The company is preparing for a critical shareholders meeting to discuss the sale and licensing of its assets and potential delisting.
For further insights into TSE:RP stock, check out TipRanks’ Stock Analysis page.
